Avita Medical (RCEL)
(Delayed Data from NSDQ)
$10.83 USD
+0.41 (3.93%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $10.85 +0.02 (0.18%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Balance Sheet
Fiscal Year End for Avita Medical Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 89 | 79 | 85 | 111 | 74 |
Receivables | 8 | 4 | 3 | 7 | 2 |
Notes Receivable | 0 | 0 | 0 | 0 | NA |
Inventories | 6 | 2 | 2 | 2 | 1 |
Other Current Assets | 2 | 2 | 1 | 1 | 1 |
Total Current Assets | 104 | 87 | 92 | 121 | 78 |
Net Property & Equipment | 2 | 1 | 1 | 1 | 1 |
Investments & Advances | 0 | 7 | 20 | 0 | NA |
Other Non-Current Assets | 0 | 0 | 0 | 0 | NA |
Deferred Charges | 0 | 0 | 0 | 0 | NA |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 3 | 1 | 1 | 1 | 0 |
Total Assets | 112 | 98 | 116 | 126 | 82 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | NA |
Accounts Payable | 4 | 3 | 3 | 3 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | NA |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 8 | 7 | 5 | 3 | 3 |
Income Taxes Payable | 0 | 0 | 0 | 0 | NA |
Other Current Liabilities | 1 | 1 | 1 | 1 | 1 |
Total Current Liabilities | 13 | 11 | 9 | 7 | 8 |
Mortgages | 0 | 0 | 0 | 0 | NA |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | NA |
Convertible Debt | 0 | 0 | 0 | 0 | NA |
Long-Term Debt | 40 | 0 | 0 | 0 | NA |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 2 |
Other Non-Current Liabilities | 8 | 3 | 1 | 2 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | NA |
Total Liabilities | 63 | 14 | 11 | 10 | 10 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | NA |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 350 | 340 | 332 | 329 | 259 |
Retained Earnings | -298 | -263 | -236 | -222 | -195 |
Other Equity | -3 | 8 | 8 | 8 | 8 |
Treasury Stock | 0 | 0 | 0 | 0 | NA |
Total Shareholder's Equity | 49 | 85 | 105 | 116 | 72 |
Total Liabilities & Shareholder's Equity | 112 | 98 | 116 | 126 | 82 |
Total Common Equity | 49 | 85 | 105 | 116 | 100,071 |
Shares Outstanding | 25.50 | 25.00 | 24.90 | 21.60 | 21.10 |
Book Value Per Share | 1.92 | 3.39 | 4.20 | 5.35 | 4,742.72 |
Fiscal Year End for Avita Medical Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 54 | 68 | 89 | 60 | 66 |
Receivables | 9 | 7 | 8 | 6 | 6 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 7 | 7 | 6 | 4 | 3 |
Other Current Assets | 3 | 4 | 2 | 3 | 2 |
Total Current Assets | 73 | 86 | 104 | 74 | 78 |
Net Property & Equipment | 7 | 4 | 2 | 2 | 2 |
Investments & Advances | 0 | 0 | 0 | 0 | 3 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 1 | 1 | 0 | 0 | 0 |
Deposits & Other Assets | 3 | 3 | 3 | 2 | 2 |
Total Assets | 88 | 97 | 112 | 81 | 86 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 4 | 4 | 3 | 4 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 8 | 6 | 8 | 7 | 6 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 2 | 1 | 2 | 4 |
Total Current Liabilities | 14 | 12 | 13 | 12 | 14 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 41 | 41 | 40 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 6 | 8 | 4 | 3 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 64 | 65 | 63 | 18 | 18 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 359 | 353 | 350 | 347 | 344 |
Retained Earnings | -332 | -317 | -298 | -291 | -282 |
Other Equity | -3 | -4 | -3 | 7 | 7 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 24 | 33 | 49 | 63 | 69 |
Total Liabilities & Shareholder's Equity | 88 | 97 | 112 | 81 | 86 |
Total Common Equity | 24 | 33 | 49 | 63 | 69 |
Shares Outstanding | 25.80 | 25.80 | 25.50 | 25.40 | 25.30 |
Book Value Per Share | 0.93 | 1.26 | 1.92 | 2.48 | 2.71 |